Up to 10 percent of all cancers are inherited. Myriad Genetic Laboratories is a leader in cancer predisposition testing, offering the most accurate, highest-quality clinical tests available to determine predisposition to cancer. Here is an overview of the tests we offer:
A genetic test for hereditary breast and
ovarian cancer
BRACAnalysis® assesses a person's risk of developing breast or ovarian cancer based on detection of mutations in the BRCA1 and BRCA2 genes.
» Read more about hereditary breast and ovarian cancer.
A genetic test for hereditary nonpolyposis
colorectal cancer (HNPCC)
COLARIS® assesses an individual's risk of developing colorectal, endometrial and other related cancers based on the detection of mutations in the MLH1, MSH2, and MSH6 genes.
» Read more about hereditary colorectal cancer and HNPCC.
A genetic test for adenomatous polyposis
syndromes
COLARIS AP® assesses an individual's risk of developing colorectal polyps and cancer based on detection of mutations in the APC and MYH genes.
» Read more about hereditary colorectal cancer and adenomatous polyposis syndromes.
A genetic test for hereditary melanoma
MELARIS® assesses an individual's risk of developing melanoma and pancreatic cancer, based on the detection of mutations in the p16 gene.